Global Generic Nifedipine Controlled-release Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 89

Published Date: 29 Jul 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Nifedipine controlled-release tablets are a type of medication used primarily to treat high blood pressure(hypertension)and certain types of chest pain (angina).Nifedipine belongs to a class of drugs known as calcium channel blockers.These tablets are formulated to release the medication slowly over time,which helps maintain a steady level of the drug in the body and can prolong its therapeutic effect.

According to our (Global Info Research) latest study, the global Generic Nifedipine Controlled-release Tablets market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Generic Nifedipine Controlled-release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Generic Nifedipine Controlled-release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Generic Nifedipine Controlled-release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Generic Nifedipine Controlled-release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Generic Nifedipine Controlled-release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Generic Nifedipine Controlled-release Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Generic Nifedipine Controlled-release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Shyndec Pharma, Simcere, Qingdao Baiyang Pharmaceutical, CR DOUBLE-CRANE, Hefei Cube Pharma, Deyao Pharma, Apichope, Nanjing Easeheal Pharma, Beijing Honglin Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Generic Nifedipine Controlled-release Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    30mg per Tablet
    60mg per Tablet

Market segment by Application
    Hypertension
    Exertional Angina
    Other

Major players covered
    Shanghai Shyndec Pharma
    Simcere
    Qingdao Baiyang Pharmaceutical
    CR DOUBLE-CRANE
    Hefei Cube Pharma
    Deyao Pharma
    Apichope
    Nanjing Easeheal Pharma
    Beijing Honglin Pharma

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Generic Nifedipine Controlled-release Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Generic Nifedipine Controlled-release Tablets, with price, sales quantity, revenue, and global market share of Generic Nifedipine Controlled-release Tablets from 2019 to 2024.
Chapter 3, the Generic Nifedipine Controlled-release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Nifedipine Controlled-release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Generic Nifedipine Controlled-release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Generic Nifedipine Controlled-release Tablets.
Chapter 14 and 15, to describe Generic Nifedipine Controlled-release Tablets sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Generic Nifedipine Controlled-release Tablets Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 30mg per Tablet
        1.3.3 60mg per Tablet
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Generic Nifedipine Controlled-release Tablets Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hypertension
        1.4.3 Exertional Angina
        1.4.4 Other
    1.5 Global Generic Nifedipine Controlled-release Tablets Market Size & Forecast
        1.5.1 Global Generic Nifedipine Controlled-release Tablets Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Generic Nifedipine Controlled-release Tablets Sales Quantity (2019-2030)
        1.5.3 Global Generic Nifedipine Controlled-release Tablets Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Shanghai Shyndec Pharma
        2.1.1 Shanghai Shyndec Pharma Details
        2.1.2 Shanghai Shyndec Pharma Major Business
        2.1.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product and Services
        2.1.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Shanghai Shyndec Pharma Recent Developments/Updates
    2.2 Simcere
        2.2.1 Simcere Details
        2.2.2 Simcere Major Business
        2.2.3 Simcere Generic Nifedipine Controlled-release Tablets Product and Services
        2.2.4 Simcere Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Simcere Recent Developments/Updates
    2.3 Qingdao Baiyang Pharmaceutical
        2.3.1 Qingdao Baiyang Pharmaceutical Details
        2.3.2 Qingdao Baiyang Pharmaceutical Major Business
        2.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product and Services
        2.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Qingdao Baiyang Pharmaceutical Recent Developments/Updates
    2.4 CR DOUBLE-CRANE
        2.4.1 CR DOUBLE-CRANE Details
        2.4.2 CR DOUBLE-CRANE Major Business
        2.4.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product and Services
        2.4.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 CR DOUBLE-CRANE Recent Developments/Updates
    2.5 Hefei Cube Pharma
        2.5.1 Hefei Cube Pharma Details
        2.5.2 Hefei Cube Pharma Major Business
        2.5.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product and Services
        2.5.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Hefei Cube Pharma Recent Developments/Updates
    2.6 Deyao Pharma
        2.6.1 Deyao Pharma Details
        2.6.2 Deyao Pharma Major Business
        2.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product and Services
        2.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Deyao Pharma Recent Developments/Updates
    2.7 Apichope
        2.7.1 Apichope Details
        2.7.2 Apichope Major Business
        2.7.3 Apichope Generic Nifedipine Controlled-release Tablets Product and Services
        2.7.4 Apichope Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Apichope Recent Developments/Updates
    2.8 Nanjing Easeheal Pharma
        2.8.1 Nanjing Easeheal Pharma Details
        2.8.2 Nanjing Easeheal Pharma Major Business
        2.8.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product and Services
        2.8.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Nanjing Easeheal Pharma Recent Developments/Updates
    2.9 Beijing Honglin Pharma
        2.9.1 Beijing Honglin Pharma Details
        2.9.2 Beijing Honglin Pharma Major Business
        2.9.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product and Services
        2.9.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Beijing Honglin Pharma Recent Developments/Updates

3 Competitive Environment: Generic Nifedipine Controlled-release Tablets by Manufacturer
    3.1 Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturer (2019-2024)
    3.3 Global Generic Nifedipine Controlled-release Tablets Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Generic Nifedipine Controlled-release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Generic Nifedipine Controlled-release Tablets Manufacturer Market Share in 2023
        3.4.3 Top 6 Generic Nifedipine Controlled-release Tablets Manufacturer Market Share in 2023
    3.5 Generic Nifedipine Controlled-release Tablets Market: Overall Company Footprint Analysis
        3.5.1 Generic Nifedipine Controlled-release Tablets Market: Region Footprint
        3.5.2 Generic Nifedipine Controlled-release Tablets Market: Company Product Type Footprint
        3.5.3 Generic Nifedipine Controlled-release Tablets Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Generic Nifedipine Controlled-release Tablets Market Size by Region
        4.1.1 Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2030)
        4.1.2 Global Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2030)
        4.1.3 Global Generic Nifedipine Controlled-release Tablets Average Price by Region (2019-2030)
    4.2 North America Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
    4.3 Europe Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
    4.4 Asia-Pacific Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
    4.5 South America Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
    4.6 Middle East & Africa Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
    5.2 Global Generic Nifedipine Controlled-release Tablets Consumption Value by Type (2019-2030)
    5.3 Global Generic Nifedipine Controlled-release Tablets Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
    6.2 Global Generic Nifedipine Controlled-release Tablets Consumption Value by Application (2019-2030)
    6.3 Global Generic Nifedipine Controlled-release Tablets Average Price by Application (2019-2030)

7 North America
    7.1 North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
    7.2 North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
    7.3 North America Generic Nifedipine Controlled-release Tablets Market Size by Country
        7.3.1 North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
        7.3.2 North America Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
    8.2 Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
    8.3 Europe Generic Nifedipine Controlled-release Tablets Market Size by Country
        8.3.1 Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
        8.3.2 Europe Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Generic Nifedipine Controlled-release Tablets Market Size by Region
        9.3.1 Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
    10.2 South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
    10.3 South America Generic Nifedipine Controlled-release Tablets Market Size by Country
        10.3.1 South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
        10.3.2 South America Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Generic Nifedipine Controlled-release Tablets Market Size by Country
        11.3.1 Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Generic Nifedipine Controlled-release Tablets Market Drivers
    12.2 Generic Nifedipine Controlled-release Tablets Market Restraints
    12.3 Generic Nifedipine Controlled-release Tablets Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Generic Nifedipine Controlled-release Tablets and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Generic Nifedipine Controlled-release Tablets
    13.3 Generic Nifedipine Controlled-release Tablets Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Generic Nifedipine Controlled-release Tablets Typical Distributors
    14.3 Generic Nifedipine Controlled-release Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Shanghai Shyndec Pharma Basic Information, Manufacturing Base and Competitors
 Table 4. Shanghai Shyndec Pharma Major Business
 Table 5. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product and Services
 Table 6. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Shanghai Shyndec Pharma Recent Developments/Updates
 Table 8. Simcere Basic Information, Manufacturing Base and Competitors
 Table 9. Simcere Major Business
 Table 10. Simcere Generic Nifedipine Controlled-release Tablets Product and Services
 Table 11. Simcere Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Simcere Recent Developments/Updates
 Table 13. Qingdao Baiyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 14. Qingdao Baiyang Pharmaceutical Major Business
 Table 15. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product and Services
 Table 16. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Qingdao Baiyang Pharmaceutical Recent Developments/Updates
 Table 18. CR DOUBLE-CRANE Basic Information, Manufacturing Base and Competitors
 Table 19. CR DOUBLE-CRANE Major Business
 Table 20. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product and Services
 Table 21. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. CR DOUBLE-CRANE Recent Developments/Updates
 Table 23. Hefei Cube Pharma Basic Information, Manufacturing Base and Competitors
 Table 24. Hefei Cube Pharma Major Business
 Table 25. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product and Services
 Table 26. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Hefei Cube Pharma Recent Developments/Updates
 Table 28. Deyao Pharma Basic Information, Manufacturing Base and Competitors
 Table 29. Deyao Pharma Major Business
 Table 30. Deyao Pharma Generic Nifedipine Controlled-release Tablets Product and Services
 Table 31. Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Deyao Pharma Recent Developments/Updates
 Table 33. Apichope Basic Information, Manufacturing Base and Competitors
 Table 34. Apichope Major Business
 Table 35. Apichope Generic Nifedipine Controlled-release Tablets Product and Services
 Table 36. Apichope Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Apichope Recent Developments/Updates
 Table 38. Nanjing Easeheal Pharma Basic Information, Manufacturing Base and Competitors
 Table 39. Nanjing Easeheal Pharma Major Business
 Table 40. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product and Services
 Table 41. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Nanjing Easeheal Pharma Recent Developments/Updates
 Table 43. Beijing Honglin Pharma Basic Information, Manufacturing Base and Competitors
 Table 44. Beijing Honglin Pharma Major Business
 Table 45. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product and Services
 Table 46. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Beijing Honglin Pharma Recent Developments/Updates
 Table 48. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 49. Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 50. Global Generic Nifedipine Controlled-release Tablets Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 51. Market Position of Manufacturers in Generic Nifedipine Controlled-release Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 52. Head Office and Generic Nifedipine Controlled-release Tablets Production Site of Key Manufacturer
 Table 53. Generic Nifedipine Controlled-release Tablets Market: Company Product Type Footprint
 Table 54. Generic Nifedipine Controlled-release Tablets Market: Company Product Application Footprint
 Table 55. Generic Nifedipine Controlled-release Tablets New Market Entrants and Barriers to Market Entry
 Table 56. Generic Nifedipine Controlled-release Tablets Mergers, Acquisition, Agreements, and Collaborations
 Table 57. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 58. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2024) & (K Units)
 Table 59. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Region (2025-2030) & (K Units)
 Table 60. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2024) & (USD Million)
 Table 61. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2025-2030) & (USD Million)
 Table 62. Global Generic Nifedipine Controlled-release Tablets Average Price by Region (2019-2024) & (US$/Unit)
 Table 63. Global Generic Nifedipine Controlled-release Tablets Average Price by Region (2025-2030) & (US$/Unit)
 Table 64. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 65. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 66. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. Global Generic Nifedipine Controlled-release Tablets Average Price by Type (2019-2024) & (US$/Unit)
 Table 69. Global Generic Nifedipine Controlled-release Tablets Average Price by Type (2025-2030) & (US$/Unit)
 Table 70. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 71. Global Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 72. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Application (2019-2024) & (USD Million)
 Table 73. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Application (2025-2030) & (USD Million)
 Table 74. Global Generic Nifedipine Controlled-release Tablets Average Price by Application (2019-2024) & (US$/Unit)
 Table 75. Global Generic Nifedipine Controlled-release Tablets Average Price by Application (2025-2030) & (US$/Unit)
 Table 76. North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 77. North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 78. North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 79. North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 80. North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 81. North America Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 82. North America Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 83. North America Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 84. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 85. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 86. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 87. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 88. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 89. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 90. Europe Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 91. Europe Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 92. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 93. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 94. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 95. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 96. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2024) & (K Units)
 Table 97. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity by Region (2025-2030) & (K Units)
 Table 98. Asia-Pacific Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2024) & (USD Million)
 Table 99. Asia-Pacific Generic Nifedipine Controlled-release Tablets Consumption Value by Region (2025-2030) & (USD Million)
 Table 100. South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 101. South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 102. South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 103. South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 104. South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 105. South America Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 106. South America Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 107. South America Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 108. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 109. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 110. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 111. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 112. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 113. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 114. Middle East & Africa Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 115. Middle East & Africa Generic Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 116. Generic Nifedipine Controlled-release Tablets Raw Material
 Table 117. Key Manufacturers of Generic Nifedipine Controlled-release Tablets Raw Materials
 Table 118. Generic Nifedipine Controlled-release Tablets Typical Distributors
 Table 119. Generic Nifedipine Controlled-release Tablets Typical Customers


List of Figures
 Figure 1. Generic Nifedipine Controlled-release Tablets Picture
 Figure 2. Global Generic Nifedipine Controlled-release Tablets Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type in 2023
 Figure 4. 30mg per Tablet Examples
 Figure 5. 60mg per Tablet Examples
 Figure 6. Global Generic Nifedipine Controlled-release Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application in 2023
 Figure 8. Hypertension Examples
 Figure 9. Exertional Angina Examples
 Figure 10. Other Examples
 Figure 11. Global Generic Nifedipine Controlled-release Tablets Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Generic Nifedipine Controlled-release Tablets Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Generic Nifedipine Controlled-release Tablets Sales Quantity (2019-2030) & (K Units)
 Figure 14. Global Generic Nifedipine Controlled-release Tablets Price (2019-2030) & (US$/Unit)
 Figure 15. Global Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Generic Nifedipine Controlled-release Tablets by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Generic Nifedipine Controlled-release Tablets Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Generic Nifedipine Controlled-release Tablets Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Generic Nifedipine Controlled-release Tablets Average Price by Type (2019-2030) & (US$/Unit)
 Figure 30. Global Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2019-2030)
 Figure 32. Global Generic Nifedipine Controlled-release Tablets Average Price by Application (2019-2030) & (US$/Unit)
 Figure 33. North America Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Generic Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Generic Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Generic Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 73. Generic Nifedipine Controlled-release Tablets Market Drivers
 Figure 74. Generic Nifedipine Controlled-release Tablets Market Restraints
 Figure 75. Generic Nifedipine Controlled-release Tablets Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Generic Nifedipine Controlled-release Tablets in 2023
 Figure 78. Manufacturing Process Analysis of Generic Nifedipine Controlled-release Tablets
 Figure 79. Generic Nifedipine Controlled-release Tablets Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Shanghai Shyndec Pharma
Simcere
Qingdao Baiyang Pharmaceutical
CR DOUBLE-CRANE
Hefei Cube Pharma
Deyao Pharma
Apichope
Nanjing Easeheal Pharma
Beijing Honglin Pharma

Related Reports

Global Generic Nifedipine Controlled-release Tablets Supply, Demand and Key Producers, 2024-2030

Global Generic Nifedipine Controlled-release Tablets Supply, Demand and Key Producers, 2024-2030

date 29 Jul 2024

date Pharma & Healthcare

Nifedipine controlled-release tablets are a type of medication used primarily to treat high blood pressure(hypertension)and certain types of chest pain (angina).Nifedipine belongs to a class of drugs known as calcium channel blockers.These tablets are formulated to release the medication slowly over time,which helps maintain a steady level of the drug in the body and can prolong its therapeutic effect.

Product Tags

Generic Nifedipine Controlled-release Tablets

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>